{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:04:41Z","timestamp":1761822281486,"version":"build-2065373602"},"reference-count":46,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","award":["CPII21\/00004","PI18\/00042"],"award-info":[{"award-number":["CPII21\/00004","PI18\/00042"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["RD21\/0002\/0025"],"award-info":[{"award-number":["RD21\/0002\/0025"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","revespcardiol.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.rec.2023.04.005","type":"journal-article","created":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T01:33:00Z","timestamp":1684287180000},"page":"1013-1020","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Serum and genetic markers related to rapid clinical progression of coronary artery disease"],"prefix":"10.1016","volume":"76","author":[{"given":"Tamara","family":"Garc\u00eda-Camarero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Remuzgo-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda","family":"Genre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"L\u00f3pez-Mej\u00edas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ver\u00f3nica","family":"Pulito-Cueto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Veiga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae-Hyun","family":"Lee Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferm\u00edn","family":"S\u00e1inz Laso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aritz","family":"Gil Ongay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel \u00c1ngel","family":"Gonz\u00e1lez-Gay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 M.","family":"de la Torre Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rec.2023.04.005_bib0235","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/CIRCRESAHA.117.305637","article-title":"Do plaques rapidly progress prior to myocardial infarction? The interplay between plaque vulnerability and progression","volume":"117","author":"Ahmadi","year":"2015","journal-title":"Circ Res."},{"key":"10.1016\/j.rec.2023.04.005_bib0240","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1161\/01.CIR.100.9.903","article-title":"Process of progression of coronary artery lesions from mild or moderate stenosis to moderate or severe stenosis: A study based on four serial coronary arteriograms per year","volume":"100","author":"Yokoya","year":"1999","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2023.04.005_bib0245","doi-asserted-by":"crossref","first-page":"634983","DOI":"10.1155\/2015\/634983","article-title":"Rapid Progression of Coronary Atherosclerosis: A Review","volume":"2015","author":"Shah","year":"2015","journal-title":"Thrombosis."},{"key":"10.1016\/j.rec.2023.04.005_bib0250","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1053\/euhj.2000.2588","article-title":"Increased plasma endothelin levels in angina patients with rapid coronary artery disease progression","volume":"22","author":"Zouridakis","year":"2001","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2023.04.005_bib0255","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1161\/01.CIR.91.4.948","article-title":"Rapid angiographic progression of coronary artery disease in patients with elevated lipoprotein(a)","volume":"91","author":"Terres","year":"1995","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2023.04.005_bib0260","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1161\/01.CIR.0000142664.18739.92","article-title":"Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris","volume":"110","author":"Zouridakis","year":"2004","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2023.04.005_bib0265","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1253\/circj.CJ-08-0185","article-title":"C-reactive protein elevation and rapid angiographic progression of nonculprit lesion in patients with non-ST-segment elevation acute coronary syndrome","volume":"72","author":"Nakachi","year":"2008","journal-title":"Circ J."},{"key":"10.1016\/j.rec.2023.04.005_bib0270","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/MCA.0b013e3283441d0b","article-title":"Osteopontin plasma levels and accelerated atherosclerosis in patients with CAD undergoing PCI: a prospective clinical study","volume":"22","author":"Mazzone","year":"2011","journal-title":"Coron Artery Dis."},{"key":"10.1016\/j.rec.2023.04.005_bib0275","first-page":"21","article-title":"Rapid coronary artery disease progression and angiographic stenosis morphology","volume":"1","author":"Kaski","year":"2000","journal-title":"Ital Heart J."},{"key":"10.1016\/j.rec.2023.04.005_bib0280","first-page":"2353","article-title":"Rapid angiographic progression of coronary artery disease in patients with elevated lipoprotein(a)","volume":"92","author":"Enas","year":"1995","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2023.04.005_bib0285","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1161\/01.CIR.92.8.2058","article-title":"Rapid angiographic progression of coronary artery disease in patients with angina pectoris. The role of complex stenosis morphology","volume":"92","author":"Kaski","year":"1995","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2023.04.005_bib0290","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.atherosclerosis.2021.03.009","article-title":"Atherogenic index of plasma and the risk of rapid progression of coronary atherosclerosis beyond traditional risk factors","volume":"324","author":"Won","year":"2021","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.rec.2023.04.005_bib0295","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.jacc.2009.09.009","article-title":"Leducq Transatlantic Network on Atherothrombosis. Inflammation in atherosclerosis: from pathophysiology to practice","volume":"54","author":"Libby","year":"2009","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2023.04.005_bib0300","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/ATVBAHA.108.179705","article-title":"Inflammation in atherosclerosis","volume":"32","author":"Libby","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"10.1016\/j.rec.2023.04.005_bib0305","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11883-015-0557-y","article-title":"The Link Between Inflammatory Disorders and Coronary Heart Disease: a Look at Recent Studies and Novel Drugs in Development","volume":"18","author":"Teague","year":"2016","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.rec.2023.04.005_bib0310","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1136\/annrheumdis-2013-205058","article-title":"Systemic inflammation and cardiovascular risk factors predict rapid progression of atherosclerosis in rheumatoid arthritis","volume":"74","author":"el Rinc\u00f3n","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.rec.2023.04.005_bib0315","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet."},{"key":"10.1016\/j.rec.2023.04.005_bib0320","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2023.04.005_bib0325","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1016\/j.jacc.2015.05.001","article-title":"Are PCSK9 Inhibitors the Next Breakthrough in the Cardiovascular Field?","volume":"65","author":"Giugliano","year":"2015","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2023.04.005_bib0330","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1001\/jama.2016.16951","article-title":"Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial","volume":"316","author":"Nicholls","year":"2016","journal-title":"JAMA."},{"key":"10.1016\/j.rec.2023.04.005_bib0335","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2023.04.005_bib0340","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.hlc.2019.04.014","article-title":"Status of PCSK9 Monoclonal Antibodies in Australia","volume":"28","author":"Scherer","year":"2019","journal-title":"Heart Lung Circ."},{"key":"10.1016\/j.rec.2023.04.005_bib0345","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2023.04.005_bib0350","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41574-018-0110-5","article-title":"Inhibiting PCSK9 - biology beyond LDL control","volume":"15","author":"Stoekenbroek","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.rec.2023.04.005_bib0355","doi-asserted-by":"crossref","first-page":"e63374","DOI":"10.1371\/journal.pone.0063374","article-title":"Lipid regulators during atherogenesis: expression of LXR, PPAR, and SREBP mRNA in the human aorta","volume":"8","author":"Shchelkunova","year":"2013","journal-title":"PLoS One."},{"key":"10.1016\/j.rec.2023.04.005_bib0360","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1515\/jomb-2016-0019","article-title":"Serum sdLDL-C and Cellular SREBP2-dependent Cholesterol Levels; is there a Challenge on Targeting PCSK9?","volume":"35","author":"Soltanmohammadi","year":"2016","journal-title":"J Med Biochem."},{"key":"10.1016\/j.rec.2023.04.005_bib0365","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.jacc.2013.07.056","article-title":"Targeting the proprotein convertase subtilisin\/kexin type 9 for the treatment of dyslipidemia and atherosclerosis","volume":"62","author":"Urban","year":"2013","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2023.04.005_bib0370","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cca.2019.09.022","article-title":"Cholesterol in LDL receptor recycling and degradation","volume":"500","author":"Yang","year":"2020","journal-title":"Clin Chim Acta."},{"key":"10.1016\/j.rec.2023.04.005_bib0375","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s13167-017-0106-6","article-title":"PCSK9 signaling pathways and their potential importance in clinical practice","volume":"8","author":"Wici\u0144ski","year":"2017","journal-title":"EPMA J."},{"key":"10.1016\/j.rec.2023.04.005_bib0380","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1620\/tjem.230.97","article-title":"Elevated lipoprotein-associated phospholipase A2 is associated with progression of nonculprit lesions after percutaneous coronary intervention","volume":"230","author":"Xin","year":"2013","journal-title":"Tohoku J Exp Med."},{"key":"10.1016\/j.rec.2023.04.005_bib0385","doi-asserted-by":"crossref","first-page":"31979","DOI":"10.1038\/srep31979","article-title":"Influence of elevated-CRP level-related polymorphisms in non-rheumatic Caucasians on the risk of subclinical atherosclerosis and cardiovascular disease in rheumatoid arthritis","volume":"6","author":"L\u00f3pez-Mej\u00edas","year":"2016","journal-title":"Sci Rep."},{"key":"10.1016\/j.rec.2023.04.005_bib0390","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.hjc.2017.02.002","article-title":"The -174 G>C Interleukin-6 Gene Polymorphism is Associated with Angiographic Progression of Coronary Artery Disease over a 4-Year Period","volume":"58","author":"Toutouzas","year":"2017","journal-title":"Hellenic J Cardiol."},{"key":"10.1016\/j.rec.2023.04.005_bib0395","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ehj.2003.12.017","article-title":"C-reactive protein elevation and disease activity in patients with coronary artery disease","volume":"25","author":"Arroyo-Espliguero","year":"2004","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2023.04.005_bib0400","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0735-1097(01)01804-6","article-title":"C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina","volume":"39","author":"Zebrack","year":"2002","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2023.04.005_bib0405","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1053\/euhj.1999.2207","article-title":"Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6","volume":"21","author":"Woods","year":"2000","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2023.04.005_bib0410","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1161\/01.CIR.101.15.1767","article-title":"Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men","volume":"101","author":"Ridker","year":"2000","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2023.04.005_bib0415","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.4238\/2015.April.10.29","article-title":"Role of interleukin-6 gene polymorphisms in the risk of coronary artery disease","volume":"14","author":"Wang","year":"2015","journal-title":"Genet Mol Res."},{"key":"10.1016\/j.rec.2023.04.005_bib0420","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.amjcard.2004.07.119","article-title":"Platelet aggregation inhibition blocks C-reactive protein and interleukin-6 (IL-6) elevation after the coronary angioplasty: effect of the -174 G\/C IL-6 gene polymorphism","volume":"94","author":"Merino","year":"2004","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.rec.2023.04.005_bib0425","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1053\/euhj.2001.2678","article-title":"The interleukin-6-174 G\/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men","volume":"22","author":"Humphries","year":"2001","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2023.04.005_bib0430","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.atherosclerosis.2003.08.029","article-title":"Interleukin-6 serum levels and genotypes influence the risk for myocardial infarction","volume":"171","author":"Bennet","year":"2003","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.rec.2023.04.005_bib0435","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1161\/01.ATV.0000084640.21712.9C","article-title":"Human CRP gene polymorphism influences CRP levels: implications for the prediction and pathogenesis of coronary heart disease","volume":"23","author":"Brull","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"10.1016\/j.rec.2023.04.005_bib0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41021-021-00172-8","article-title":"The effect of polymorphisms (174G>C and 572C>G) on the Interleukin-6 gene in coronary artery disease: a systematic review and meta-analysis","volume":"43","author":"Salari","year":"2021","journal-title":"Genes Environ."},{"key":"10.1016\/j.rec.2023.04.005_bib0445","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00011-021-01505-7","article-title":"Association of interleukin 6-174 G\/C polymorphism with coronary artery disease and circulating IL-6 levels: a systematic review and meta-analysis","volume":"70","author":"Rai","year":"2021","journal-title":"Inflamm Res."},{"key":"10.1016\/j.rec.2023.04.005_bib0450","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","volume":"354","author":"Cohen","year":"2006","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2023.04.005_bib0455","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1056\/NEJMc0707445","article-title":"A PCSK9 missense variant associated with a reduced risk of early-onset myocardial infarction","volume":"358","author":"Kathiresan","year":"2008","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2023.04.005_bib0460","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.5551\/jat.60152","article-title":"Small Dense Low-Density Lipoprotein Cholesterol: A Residual Risk for Rapid Progression of Non-Culprit Coronary Lesion in Patients with Acute Coronary Syndrome","volume":"28","author":"Sekimoto","year":"2021","journal-title":"J Atheroscler Thromb."}],"container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585723001299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585723001299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:02:25Z","timestamp":1761822145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1885585723001299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1885585723001299"],"URL":"https:\/\/doi.org\/10.1016\/j.rec.2023.04.005","relation":{},"ISSN":["1885-5857"],"issn-type":[{"type":"print","value":"1885-5857"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum and genetic markers related to rapid clinical progression of coronary artery disease","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rec.2023.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.recesp.2023.04.009","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Sociedad Espa\u00f1ola de Cardiolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}